Overview

Feasibility of Treatment for Vaping Cessation

Status:
Not yet recruiting

Trial end date:
2024-12-01

Target enrollment:

Participant gender:

Summary

Researchers are gathering information on the feasibility of treating e-cigarette users with 12-weeks of varenicline (Chantix®) in assisting with stopping the use of e-cigarettes.

Phase:

Early Phase 1

Details

Lead Sponsor:

Mayo Clinic

Treatments:

Varenicline